+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levalbuterol"

Short-Acting B2 Agonists Market Report 2025 - Product Thumbnail Image

Short-Acting B2 Agonists Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Pulmonary Drugs Market Report 2025 - Product Thumbnail Image

Pulmonary Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Salbutamol Oral Liquid Global Market Report 2025 - Product Thumbnail Image

Salbutamol Oral Liquid Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
From
Cough Hypersensitivity Syndrome Market Report 2025 - Product Thumbnail Image

Cough Hypersensitivity Syndrome Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
  • 9 Results (Page 1 of 1)
Loading Indicator

Levalbuterol is a bronchodilator drug used to treat asthma and other respiratory conditions. It is a short-acting beta-2 agonist, meaning it works by relaxing the muscles in the airways, allowing more air to flow through. It is often used as a rescue medication for acute asthma attacks, and is also used to treat chronic obstructive pulmonary disease (COPD). Levalbuterol is available in both oral and inhalation forms, and is often used in combination with other medications. Levalbuterol is a widely used drug in the respiratory market, and is available from many pharmaceutical companies. Some of the companies that produce levalbuterol include GlaxoSmithKline, Merck, Mylan, and Teva Pharmaceuticals. Show Less Read more